SCHEMBL5737635

SCHEMBL5737635

COc1ccc(F)cc1C(=O)c1cnc(N(C2CCNCC2)S(=O)(=O)C(F)(F)F)nc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 16/20 0.53
CDK4 P11802 15/20 0.53
CCND1 P24385 15/20 0.53
CDK2 P24941 15/20 0.53
CASK O14936 1/20 0.38
ROCK2 O75116 1/20 0.38
CDKL5 O76039 1/20 0.38
STK10 O94804 1/20 0.38
CDK14 O94921 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
MAK P20794 1/20 0.38
CDK11B P21127 1/20 0.38
TTK P33981 1/20 0.38
CLK1 P49759 1/20 0.38
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CDK7 P50613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517629 0.91 CDK1 (0.57) CDK1CDK4CCND1CDK2CASK
SCHEMBL4363543 0.89 CDK1 (0.54) CDK1CDK4CCND1CDK2CASK
SCHEMBL5739352 0.89 CDK1 (0.52) CDK1CDK4CCND1CDK2CASK
SCHEMBL5738159 0.88 CDK1 (0.53) CDK1CDK4CCND1CDK2CASK
SCHEMBL4360004 0.87 CDK1 (0.51) CDK1CDK4CCND1CDK2CASK
SCHEMBL5737753 0.87 CDK1 (0.51) CDK1CDK4CCND1CDK2CASK
SCHEMBL4355978 0.87 CDK1 (0.55) CDK1CDK4CCND1CDK2CASK
SCHEMBL4355674 0.87 CDK1 (0.55) CDK1CDK4CCND1CDK2CASK
SCHEMBL5738145 0.87 CDK1 (0.55) CDK1CDK4CCND1CDK2CASK
SCHEMBL5738044 0.86 CDK1 (0.50) CDK1CDK4CCND1CDK2CASK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628619-A2 4-AMINOPYRIMIDINE-5-ONE F.HOFFMANN-LA ROCHE AG (CH) 2006-03-01 EP disclosed
WO-2004069139-A2 4-AMINOPYRIMIDIN-5-YL-METHANONE DERIVATIVES FOR INHIBITION OF CDK4 ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed